{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:44:31Z","timestamp":1771461871563,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1985,1,1]],"date-time":"1985-01-01T00:00:00Z","timestamp":473385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1985]]},"DOI":"10.1007\/bf00547412","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T09:58:27Z","timestamp":1100858307000},"page":"131-147","source":"Crossref","is-referenced-by-count":58,"title":["Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man"],"prefix":"10.1007","volume":"29","author":[{"given":"A.","family":"Wellstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Palm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. F.","family":"Pitschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. G.","family":"Belz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/BF00541922","volume":"26","author":"EJ Ari\u00ebns","year":"1984","unstructured":"Ari\u00ebns EJ (1984) Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur J Clin Pharmacol 26: 663?668","journal-title":"Eur J Clin Pharmacol"},{"key":"CR2","first-page":"48","volume":"14","author":"O Arunlakshana","year":"1959","unstructured":"Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14: 48?58","journal-title":"Br J Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-7091-8566-7","volume-title":"Beta-Rezeptoren-Blockade. Klinische Pharmakologie und klinisch therapeutische Anwendung","author":"Bonelli","year":"1979","unstructured":"Bonelli (1979) Beta-Rezeptoren-Blockade. Klinische Pharmakologie und klinisch therapeutische Anwendung. Springer, Wien New York"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJM198207223070401","volume":"307","author":"MR Bristow","year":"1982","unstructured":"Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB (1982) Decreased catecholamine sensitivity and ?-adrenergic-receptor density in failing human hearts. N Engl J Med 307: 205?211","journal-title":"N Engl J Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1474-8673.1982.tb00477.x","volume":"2","author":"KJ Broadley","year":"1982","unstructured":"Broadley KJ (1982) Cardiac adrenoceptors. J Auton Pharmacol 2: 119?145","journal-title":"J Auton Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/0024-3205(81)90490-2","volume":"29","author":"OE Brodde","year":"1981","unstructured":"Brodde OE, Engel G, Hoyer D, Bock KD, Weber F (1981) The ?-adrenergic receptor in human lymphocytes: Subclassification by the use of a new radio-ligand, (+\/-)125-Iodocyanopindolol. Life Sci 29: 2189?2198","journal-title":"Life Sci"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/01.RES.53.6.752","volume":"53","author":"OE Brodde","year":"1983","unstructured":"Brodde OE, Karad K, Zerkowski HR, Rohm N, Reidemeister JC (1983) Coexistence of ?1- and ?2-adrenoceptors in human right atrium. Direct identification by (+\/-)125-Iodocyanopindolol binding. Circ Res 53: 752?758","journal-title":"Circ Res"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0140-6736(67)90057-8","volume":"1","author":"DA Chamberlain","year":"1967","unstructured":"Chamberlain DA, Turner P, Sneddon JM (1967) Effects of atropine on heart-rate in healthy man. Lancet 1: 12?15","journal-title":"Lancet"},{"issue":"Suppl 4","key":"CR9","first-page":"26","volume":"52","author":"C Chidsey","year":"1976","unstructured":"Chidsey C, Pine M, Favrot L, Smith S, Leonetti G, Morselli P, Zanchetti A (1976) The use of drug concentration measurements in studies of the therapeutic responses to propranolol. Postgrad Med J 52 [Suppl 4]: 26?32","journal-title":"Postgrad Med J"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF01059272","volume":"9","author":"WA Colburn","year":"1981","unstructured":"Colburn WA (1981) Simultaneous pharmacokinetic and pharmacodynamic modeling. J Pharmacokinet Biopharm 9: 367?388","journal-title":"J Pharmacokinet Biopharm"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/bmj.3.5725.731","volume":"3","author":"DJ Coltart","year":"1970","unstructured":"Coltart DJ, Shand DG (1970) Plasma propranolol levels in the quantitative assessment of ?-adrenergic blockade in man. Br Med J 3: 731?734","journal-title":"Br Med J"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2125.1975.tb02772.x","volume":"2","author":"MF Cuthbert","year":"1975","unstructured":"Cuthbert MF, Collins RF (1975) Plasma levels and ?-adrenoceptor blockade with acebutolol, practolol and propranolol in man. Br J Clin Pharmacol 2: 49?55","journal-title":"Br J Clin Pharmacol"},{"key":"CR13","first-page":"354","volume":"208","author":"HB Daniell","year":"1979","unstructured":"Daniell HB, Walle T, Gaffney TE, Webb JG (1979) Stimulation-induced release of propranolol and norepinephrine from adrenergic neurons. J Pharmacol Exp Ther 208: 354?359","journal-title":"J Pharmacol Exp Ther"},{"key":"CR14","first-page":"5","volume":"21","author":"A Lean De","year":"1982","unstructured":"De Lean A, Hancock AA, Lefkowitz RJ (1982) Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol Pharmacol 21: 5?16","journal-title":"Mol Pharmacol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/0006-2952(83)90046-1","volume":"32","author":"M Delhaye","year":"1983","unstructured":"Delhaye M, Taton G, Camus JC, Chatelain P, Robberecht P, Waelbroeck M, Christophe J (1983) Effects of full and partial ?-adrenergic agonists and antagonists on human lung adenylate cyclase. Biochem Pharmacol 32: 1831?1835","journal-title":"Biochem Pharmacol"},{"key":"CR16","first-page":"195","volume-title":"Pharmacology of antihypertensive drugs","author":"JD Fitzgerald","year":"1980","unstructured":"Fitzgerald JD (1980) Propranolol. In: A Scriabine (ed) Pharmacology of antihypertensive drugs. Raven Press, New York, pp 195?208"},{"key":"CR17","first-page":"339","volume":"181","author":"WW Fleming","year":"1972","unstructured":"Fleming WW, Westfall DP, De la Lande IS, Jellett LB (1972) Lognormal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues. J Pharmacol Exp Ther 181: 339?345","journal-title":"J Pharmacol Exp Ther"},{"key":"CR18","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-09271-2","volume-title":"Pharmakokinetik","author":"E Gladtke","year":"1977","unstructured":"Gladtke E, v Hattingberg HM (1977) Pharmakokinetik, (2nd edn). Springer, Berlin Heidelberg New York","edition":"2nd edn"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2125.1980.tb01769.x","volume":"10","author":"R Gugler","year":"1980","unstructured":"Gugler R, Krist K, Raczinski H, H\u00f6ffgen H, Bodem G (1980) Comparative pharmacodynamics and plasma levels of ?-adrenoceptor blocking drugs. Br J Clin Pharmacol 10: 337?343","journal-title":"Br J Clin Pharmacol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/clpt.1981.161","volume":"30","author":"WD Hager","year":"1981","unstructured":"Hager WD, Pieniascek HJ, Perrier D, Mayersohn M, Goldberger V (1981) Assessment of beta blockade with propranolol. Clin Pharmacol Ther 30: 283?290","journal-title":"Clin Pharmacol Ther"},{"key":"CR21","first-page":"329","volume":"199","author":"HH Harms","year":"1976","unstructured":"Harms HH (1976) Isoproterenol antagonism of cardioselective ?-adrenergic receptor blocking agents: A comparative study of human and guinea-pig cardiac and bronchial ?-adrenergic receptors. J Pharmacol Exp Ther 199: 329?335","journal-title":"J Pharmacol Exp Ther"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF00566536","volume":"11","author":"HM Hattingberg v","year":"1977","unstructured":"v Hattingberg HM, Brockmeier D, Kreuter G (1977) A rotating iterative procedure (RIP) for estimating hybrid constants. Eur J Clin Pharmacol 11: 381?388","journal-title":"Eur J Clin Pharmacol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF00561057","volume":"12","author":"CLA Herwaarden van","year":"1977","unstructured":"van Herwaarden CLA, Fennis JFM, Binkhorst RA, v'ant Laar A (1977) Haemodynamic effects of adrenaline during treatment of hypertensive patients with propranolol and metoprolol. Eur J Clin Pharmacol 12: 397?402","journal-title":"Eur J Clin Pharmacol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/clpt.1984.2","volume":"35","author":"WR Hiatt","year":"1984","unstructured":"Hiatt WR, Fradl DC, Zerbe GO, Byyny RL, Nies AS (1984) Selective and nonselective ?-blockade of the peripheral circulation. Clin Pharmacol Ther 35: 12?18","journal-title":"Clin Pharmacol Ther"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0163-7258(82)90051-1","volume":"16","author":"NH Holford","year":"1982","unstructured":"Holford NH, Sheiner LB (1982) Kinetics of pharmacologic response. Pharmacol Ther 16: 143?166","journal-title":"Pharmacol Ther"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/clpt.1982.204","volume":"32","author":"KKP Hui","year":"1982","unstructured":"Hui KKP, Conolly ME, Tashkin DP (1982) Reversal of human lymphocyte ?-adrenoceptor desensitization by glucocorticoids. Clin Pharmacol Ther 32: 566?576","journal-title":"Clin Pharmacol Ther"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2125.1983.tb02228.x","volume":"16","author":"GA Hurwitz","year":"1983","unstructured":"Hurwitz GA, Webb JG, Walle T, Bai SA, Daniell HB, Gourley L, Loadholt CB, Gaffney TE (1983) Exercise-induced increments in plasma levels of propranolol and noradrenaline. Br J Clin Pharmacol 16: 599?608","journal-title":"Br J Clin Pharmacol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00560252","volume":"14","author":"T Ishizaki","year":"1978","unstructured":"Ishizaki T, Tawara K (1978) Comparison of disposititon and effect to timolol and propranolol on exercise tachycardia. Eur J Clin Pharmacol 14: 7?14","journal-title":"Eur J Clin Pharmacol"},{"key":"CR29","first-page":"223","volume":"27","author":"T Ishizaki","year":"1980","unstructured":"Ishizaki T (1980) Likely explanation for longer duration of pharmacological (antianginal) effects of propranolol in relation to its short half-life. Res Commun Chem Pathol Pharmacol 27: 223?239","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev.pa.19.040179.000325","volume":"19","author":"ZH Israili","year":"1979","unstructured":"Israili ZH (1979) Correlation of pharmacological effects with plasma levels of antihypertensive drugs in man. Ann Rev Pharmacol Toxicol 19: 25?52","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF01065188","volume":"8","author":"AW Kelman","year":"1980","unstructured":"Kelman AW, Whiting B (1980) Modeling of drug response in individual subjects. J Pharmacokinet Biopharm 8: 115?130","journal-title":"J Pharmacokinet Biopharm"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF00504372","volume":"325","author":"IJ Kopin","year":"1984","unstructured":"Kopin IJ, Zukowska-Grojec Z, Bayorh MA, Goldstein DS (1984) Estimation of intrasynaptic norepinephrine concentrations at vascular neuroeffector junctions in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 325: 298?305","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/clpt.1984.20","volume":"35","author":"GJL Leede de","year":"1984","unstructured":"de Leede GJL, Hug CC, de Lange S, de Boer AG, Breimer DD (1984) Rectal and intravenous propranolol infusion to steady state: Kinetics and ?-receptor blockade. Clin Pharmacol Ther 35: 148?155","journal-title":"Clin Pharmacol Ther"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/10915818309140723","volume":"2","author":"B Lemmer","year":"1983","unstructured":"Lemmer B, Bathe K, Lang PH, Neumann G, Winkler H (1983) Chronopharmacology of ?-adrenoceptor-blocking drugs: Pharmacokinetic and pharmacodynamic studies in rats. J Am Coll Toxicol 2: 347?357","journal-title":"J Am Coll Toxicol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cpt196673362","volume":"7","author":"G Levy","year":"1966","unstructured":"Levy G (1966) Kinetics of pharmacologic effects. Clin Pharmacol Ther 7: 362?372","journal-title":"Clin Pharmacol Ther"},{"key":"CR36","first-page":"4","volume-title":"Concepts in biochemical pharmacology, part 3","author":"G Levy","year":"1975","unstructured":"Levy G, Gibaldi M (1975) Pharmacokinetics. In: JR Gillette, JR Mitchell, P Randall (eds) Concepts in biochemical pharmacology, part 3. Springer, Berlin Heidelberg New York, pp 4?34"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2125.1978.tb00835.x","volume":"6","author":"J McAinsh","year":"1978","unstructured":"McAinsh J, Baber NS, Smith R, Young J (1978) Pharmacokinetic and pharmacodynamic studies with long-acting propranolol. Br J Clin Pharmacol 6: 115?121","journal-title":"Br J Clin Pharmacol"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/cpt1975186708","volume":"18","author":"DG McDevitt","year":"1975","unstructured":"McDevitt DG, Shand DG (1975) Plasma concentrations and the time-course of ?-blockade due to propranolol. Clin Pharmacol Ther 18: 708?713","journal-title":"Clin Pharmacol Ther"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/clpt.1982.225","volume":"32","author":"JF Mullane","year":"1982","unstructured":"Mullane JF, Kaufman J, Dvornik D, Coelho J (1982) Propranolol dosage, plasma concentration, and ?-blockade. Clin Pharmacol Ther 32: 692?700","journal-title":"Clin Pharmacol Ther"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/clpt.1981.60","volume":"29","author":"FE Okupa","year":"1981","unstructured":"Okupa FE, Daneshmend TK, Shrosbree E, Roberts CJC (1981) Dose response studies of indenolol, a ?-adrenoceptor blocker. Clin Pharmacol Ther 29: 434?439","journal-title":"Clin Pharmacol Ther"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/clpt.1984.130","volume":"36","author":"R Platzer","year":"1984","unstructured":"Platzer R, Galeazzi RL, Niederberger W, Rosenthaler J (1984) Simultaneous modeling of bopindolol kinetics and dynamics. Clin Pharmacol Ther 36: 5?13","journal-title":"Clin Pharmacol Ther"},{"key":"CR42","first-page":"169","volume":"24","author":"P Robberecht","year":"1983","unstructured":"Robberecht P, Delhaye M, Taton G, De Neef P, Waelbroeck M, De Smet JM, Leclerc JL, Chatelain P, Christophe J (1983) The human heart ?-adrenergic receptors. I. Heterogeneity of the binding sites: Presence of 50% ?1- and 50% ?2-adrenergic receptors. Mol Pharmacol 24: 169?173","journal-title":"Mol Pharmacol"},{"key":"CR43","first-page":"324","volume":"226","author":"PM Russell","year":"1983","unstructured":"Russell PM, Webb JG, Walle T, Daniell HB, Privitera PJ, Gaffney TE (1983) Adrenergic nerve stimulation-induced release of propranolol from the perfused hindlimb and spleen of the dog and associated changes in postjunctional response. J Pharmacol Exp Ther 226: 324?329","journal-title":"J Pharmacol Exp Ther"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.pa.19.040179.001413","volume":"19","author":"A Scriabine","year":"1979","unstructured":"Scriabine A (1979) ?-adrenoceptor blocking drugs in hypertension. Ann Rev Pharmacol Toxicol 19: 269?284","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/clpt.1980.83","volume":"27","author":"MJ Serlin","year":"1980","unstructured":"Serlin MJ, Orme LE, Baber NS, Sibeon RG, Laws E, Breckenridge A (1980) Propranolol in the control of blood pressure: A dose-response study. Clin Pharmacol Ther 27: 586?592","journal-title":"Clin Pharmacol Ther"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1016\/S0021-9258(18)32689-9","volume":"258","author":"M Stachelin","year":"1983","unstructured":"Stachelin M, Simons P, Jaeggi K, Wigger N (1983) CGP 12177. A hydrophilic ?-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells. J Biol Chem 258: 3496?3502","journal-title":"J Biol Chem"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0024-3205(83)90796-8","volume":"33","author":"GL Stiles","year":"1983","unstructured":"Stiles GL, Taylor S, Lefkowitz RJ (1983a) Human cardiac ?-adrenergic receptors: Subtype heterogeneity delineated by direct radioligand binding. Life Sci 33: 467?473","journal-title":"Life Sci"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1016\/S0021-9258(20)82084-5","volume":"258","author":"GL Stiles","year":"1983","unstructured":"Stiles GL, Strasser RH, Lavin TN, Jones LR, Caron MC, Lefkowitz RJ (1983b) The cardiac ?-adrenergic receptor. Structural similarities of ?1 and ?2-receptor subtypes demonstrated by photoaffinity labeling. J Biol Chem 258: 8443?8449","journal-title":"J Biol Chem"},{"key":"CR49","first-page":"154","volume":"229","author":"JA Street","year":"1984","unstructured":"Street JA, Webb JG, Bright S, Gaffney TE (1984) Accumulation, subcellular localization and release of propranolol from synaptosomes of rat cerebral cortex. J Pharmacol Exp Ther 229: 154?161","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 2","key":"CR50","doi-asserted-by":"crossref","first-page":"167S","DOI":"10.1111\/j.1365-2125.1979.tb04687.x","volume":"7","author":"A Vukovich","year":"1979","unstructured":"Vukovich A, Foley JE, Brown B, Willard DA, Buckley M, O'Kelly D, Fitzgerald D, Tormey W, Darragh A (1979) Effects of ?-blockers on exercise double product (systolic blood pressure \u00d7 heart rate). Br J Clin Pharmacol 7 [Suppl 2]: 167S-172S","journal-title":"Br J Clin Pharmacol"},{"key":"CR51","first-page":"174","volume":"24","author":"M Waelbroeck","year":"1983","unstructured":"Waelbroeck M, Taton G, Delhaye M, Chatelain P, Camus JC, Pochet R, Leclerc JL, De Smet JM, Robberecht P, Christophe J (1983) The human heart ?-adrenergic receptors. II. Coupling of ?2-adrenergic receptors with the adenylate cyclase system. Molec Pharmacol 24: 174?182","journal-title":"Molec Pharmacol"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.2042-7158.1984.tb04363.x","volume":"36","author":"A Wellstein","year":"1984","unstructured":"Wellstein A, Jablonka B, Wiemer G, Palm D (1984a) Increase of Bmax-values of ?-adrenoceptor sites after chronic treatment with reserpine? Pol J Pharmacol Pharm 36: 261?269","journal-title":"Pol J Pharmacol Pharm"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF00556890","volume":"27","author":"A Wellstein","year":"1984","unstructured":"Wellstein A, Palm D, Wiemer G, Sch\u00e4fer-Korting M, Mutschler E (1984b) Simple and reliable radioreceptor assay for ?-adrenoceptor antagonists and active metabolites in native human plasma. Eur J Clin Pharmacol 27: 545?553","journal-title":"Eur J Clin Pharmacol"},{"key":"CR54","first-page":"2","volume":"35","author":"A Wellstein","year":"1985","unstructured":"Wellstein A, Palm D, Belz GG, Pitschner HF (1985) Receptor binding characteristics and pharmacokinetic properties as a tool for the prediction of clinical effects of ?-blockers. Drug Res 35: 2?6","journal-title":"Drug Res"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1042\/cs0590311","volume":"59","author":"B Whiting","year":"1980","unstructured":"Whiting B, Kelman AW (1980) The modeling of drug response. Clin Sci 59: 311?315","journal-title":"Clin Sci"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00586342","volume":"321","author":"G Wiemer","year":"1982","unstructured":"Wiemer G, Wellstein A, Palm D, v Hattingberg HM, Brockmeier D (1982) Properties of agonist binding at the ?-adrenoceptor of the rat reticulocyte. Naunyn-Schmiedeberg's Arch Pharmacol 321: 11?19","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000136287","volume":"7","author":"R Zacest","year":"1972","unstructured":"Zacest R, Koch-Weser J (1972) Relation of propranolol plasma level to ?-blockade during oral therapy. Pharmacology 7: 178?184","journal-title":"Pharmacology"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00547412.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00547412\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00547412","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T03:43:31Z","timestamp":1624938211000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00547412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1985]]}},"alternative-id":["BF00547412"],"URL":"https:\/\/doi.org\/10.1007\/bf00547412","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985]]}}}